View in EDS HTML Full Text PDF Full Text

HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.

Saved in:
Bibliographic Details
Title: HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
Authors: Zhu X; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California San Francisco, San Francisco, CA, United States., Chan E; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Pathology, Stanford Medical Center, Stanford, CA, United States., Turski ML; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States., Mendez CE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States., Hsu SC; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California San Francisco, San Francisco, CA, United States., Kumar V; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California San Francisco, San Francisco, CA, United States., Shipp C; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California San Francisco, San Francisco, CA, United States., Jindal T; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California San Francisco, San Francisco, CA, United States., Chang K; School of Medicine, University of California San Francisco, San Francisco, CA, United States., Onodera C; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States., Devine WP; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Pathology, University of California San Francisco, San Francisco, CA, United States., Grenert JP; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Pathology, University of California San Francisco, San Francisco, CA, United States., Stohr BA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Pathology, University of California San Francisco, San Francisco, CA, United States., Ding CC; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Pathology, University of California San Francisco, San Francisco, CA, United States., Stachler MD; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Pathology, University of California San Francisco, San Francisco, CA, United States., Quigley DA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Urology, University of California San Francisco, San Francisco, CA, United States., Feng FY; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, United States., Chu CE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Urology, University of California San Francisco, San Francisco, CA, United States., Porten SP; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Urology, University of California San Francisco, San Francisco, CA, United States., Chou J; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California San Francisco, San Francisco, CA, United States., Friedlander TW; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California San Francisco, San Francisco, CA, United States., Koshkin VS; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California San Francisco, San Francisco, CA, United States.
Source: The oncologist [Oncologist] 2024 Aug 05; Vol. 29 (8), pp. e1094-e1097.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1549-490X
DOI:10.1093/oncolo/oyae127